REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
Infographic

Colon Cancer – Risks, Screening Tests, and Treatments

Colon Cancer – Risks, Screening Tests, and Treatments
Colon cancer begins in the large intestine, in the final part of the digestive tract. Starting as small, benign polyps on the inside of the colon, this disease most commonly affects older adults. Over time, the polyps can develop into cancerous tumors, often without any symptoms. Regular screening tests, such as a fecal occult blood test and colonoscopy, can prevent colon cancer by detecting polyps and having them removed while they are still non-cancerous.

Many treatments can help control colon cancer, including surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. When the cancer spreads to the abdominal lining, CRS + HIPEC (Hyperthermic Intraperitoneal Chemotherapy), a revolutionary treatment that delivers heated, intense doses of chemotherapy directly into the abdomen, may be used.

Colon Cancer – Risks, Screening Tests, and Treatments
Related
new OPMD clinic
New Sheba Oculopharyngeal Muscular Dystrophy Clinic Promises Improved Care
Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic condition causing weakness in the muscles around the upper eyelids and throat. While the mutated gene that…
Read More
CAR T-Cell
CAR T-cell Therapy for Multiple Myeloma at Sheba
CAR T-cell therapy is a revolutionary blood cancer treatment that helps the body combat tumors using its own T-cells. The therapy involves collecting the patient's…
Read More
Patient Monitoring Device
News Oct 31.
Remote Patient Monitoring Device Found Effective for Early Detection of Medical Deterioration
As part of a recent Sheba study, an advanced wearable remote patient monitoring device has demonstrated efficacy in more quickly identifying patients at risk of…
Read More